by Hanna | Sep 18, 2024 | Blog Post
For life science companies of all sizes, competitive mergers and acquisitions (M&A) serve as a critical driver in bringing new and groundbreaking treatments and cures to market. In a recent article published in Concurrences Law and Economics, economists from...
by Hanna | Sep 11, 2024 | Blog Post
Protecting and promoting collaboration across the U.S. life sciences ecosystem remains a driving force in bringing new breakthroughs to patients, according to a recent report from the Center for Strategic and International Studies (CSIS). As the report’s authors...
by Hanna | Sep 4, 2024 | Blog Post
On a recent episode of the ABA Antitrust Podcast Our Curious Amalgam, Dr. Penka Kovacheva, Cornerstone Research Vice President and lead author of a paper recently published in Concurrences, “The Impact of Pharmaceutical M&A on Innovation,” discusses many ways in...
by Hanna | Aug 7, 2024 | Blog Post
A recent article from BioPharma Dive highlights the challenging landscape for biopharmaceutical initial public offerings (IPOs), and the critical role that mergers & acquisitions play in connecting promising innovations with the resources and investment needed to...
by Hanna | Jul 31, 2024 | Blog Post
In a recent article published in Concurrences Law & Economics, Cornerstone Research experts Lorenzo Cattivelli, Anca Cojoc, Penka Kovacheva and Maria Salgado highlight ways that mergers and acquisitions (M&A) can contribute to innovation in the...
by Hanna | Jul 24, 2024 | Blog Post
The U.S. House Committee on Ways and Means recently held a field hearing in Salt Lake City, UT: “Access to Health Care in America: Unleashing Medical Innovation and Economic Prosperity.” While discussing the many challenges and unique market dynamics that shape life...
